Value-Based Contracting Bill Aims For Bipartisan Political Support
Executive Summary
Legislation from Sens. Bill Cassidy and Mark Warner would eliminate barriers to value-based contracting for drugs reimbursed by public payers.
You may also be interested in...
Outcomes-Based Pricing: Can It Facilitate The Study Of Precision Dosing?
Roche's Richard Peck says adoption of outcomes-based pricing in the US could be powerful incentive to study precision dosing, although he also calls on drugmakers to put out scientific examples.
How Should Medicaid Pay For Cures? Sen. Grassley Likes Annuity Model
Finance Committee chairman wants a provision allowing Medicaid to make installment payments for high-cost curative treatments in drug pricing legislation. But Democrats worry such a model might encourage high prices.
Rx Importation: Califf's Switch Means US FDA Commissioners No Longer Uniformly Opposed
In JAMA editorial, former FDA chief supports drug importation under narrow circumstances as a way to reduce drug prices, marking a shift from his previous stance on the issue and that of other past agency heads. Essay, co-authored by former CMS Acting Administrator Andy Slavitt, calls importation "a workaround born of desperation."